InvestSMART

Prescient Therapeutics Limited (ASX: PTX) - Announcements

Current share price for PTX : $0.053 0.003 (6%)+

ASX company news and announcements for Prescient Therapeutics Limited (PTX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Prescient Therapeutics Limited (PTX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Prescient Therapeutics Limited (PTX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Prescient Therapeutics Limited (PTX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$61 Notification regarding unquoted securities - PTX 22 Jan 2025 1:14PM $0.054 $0.053 fallen by 1.85%
$61 Notification of cessation of securities - PTX 13 Jan 2025 9:47AM $0.048 $0.053 risen by 10.42%
$61 US FDA allows PTX-100 Ph2 trial 23 Dec 2024 9:26AM $0.041 $0.053 risen by 29.27%
$61 Appointment of Chief Executive Officer 17 Dec 2024 11:52AM $0.040 $0.053 risen by 32.50%
$61 Change of Director's Interest Notice 11 Dec 2024 4:14PM $0.042 $0.053 risen by 26.19%
$61 Notification regarding unquoted securities - PTX 11 Dec 2024 4:13PM $0.042 $0.053 risen by 26.19%
$61 Change of Director's Interest Notices x4 4 Dec 2024 4:15PM $0.042 $0.053 risen by 26.19%
$61 Notification of cessation of securities - PTX 4 Dec 2024 4:12PM $0.042 $0.053 risen by 26.19%
$61 Results of Annual General Meeting 14 Nov 2024 3:08PM $0.040 $0.053 risen by 32.50%
$61 Chair and CEO AGM Presentation 14 Nov 2024 11:49AM $0.040 $0.053 risen by 32.50%
$61 September 2024 Quarterly Update and Appendix 4C 31 Oct 2024 8:38AM $0.045 $0.053 risen by 17.78%
$61 Notice of Annual General Meeting/Proxy Form 14 Oct 2024 12:06PM $0.045 $0.053 risen by 17.78%
$61 Change of Director's Interest Notice 3 Oct 2024 10:34AM $0.042 $0.053 risen by 26.19%
$61 Notification of cessation of securities - PTX 2 Oct 2024 12:36PM $0.040 $0.053 risen by 32.50%
$61 Prescient CEO to step down in early 2025 12 Sep 2024 8:31AM $0.043 $0.053 risen by 23.26%
$61 PTX Presentation 5 Sep 2024 9:25AM $0.042 $0.053 risen by 26.19%
$61 Appendix 4G and Corporate Governance Statement 26 Aug 2024 9:55AM $0.047 $0.053 risen by 12.77%
$61 Appendix 4E and 2024 Annual Report 26 Aug 2024 9:54AM $0.047 $0.053 risen by 12.77%
$61 June 2024 Quarterly Update and Appendix 4C 31 Jul 2024 9:44AM $0.042 $0.053 risen by 26.19%
$61 Initial Director's Interest Notice 5 Jul 2024 12:22PM n/a $0.053 n/a
$61 PTX appoints Dr Gavin Shepherd as Non-Executive Director 4 Jul 2024 1:53PM n/a $0.053 n/a
$61 Notification of cessation of securities - PTX 4 Jun 2024 2:14PM $0.047 $0.053 risen by 13.98%
$61 Change of Director's Interest Notice 4 Jun 2024 2:09PM $0.047 $0.053 risen by 13.98%
$61 PTX invited to present at international lymphoma forum 20 May 2024 9:37AM $0.043 $0.053 risen by 23.26%
$61 March 2024 Quarterly Update and Appendix 4C 30 Apr 2024 9:57AM $0.052 $0.053 risen by 1.92%

101 - 125 of 597 results

Page 5 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.